IRIS Accounts Production v26.2.0.494 02698578 Board of Directors 1.1.25 31.12.25 31.12.25 false true false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh026985782024-12-31026985782025-12-31026985782025-01-012025-12-31026985782023-12-31026985782024-01-012024-12-31026985782024-12-3102698578ns15:EnglandWales2025-01-012025-12-3102698578ns14:PoundSterling2025-01-012025-12-3102698578ns10:Director12025-01-012025-12-3102698578ns10:PrivateLimitedCompanyLtd2025-01-012025-12-3102698578ns10:SmallEntities2025-01-012025-12-3102698578ns10:AuditExemptWithAccountantsReport2025-01-012025-12-3102698578ns10:SmallCompaniesRegimeForDirectorsReport2025-01-012025-12-3102698578ns10:SmallCompaniesRegimeForAccounts2025-01-012025-12-3102698578ns10:FullAccounts2025-01-012025-12-3102698578ns10:Director22025-01-012025-12-3102698578ns10:CompanySecretary12025-01-012025-12-3102698578ns10:RegisteredOffice2025-01-012025-12-3102698578ns5:CurrentFinancialInstruments2025-12-3102698578ns5:CurrentFinancialInstruments2024-12-3102698578ns5:ShareCapital2025-12-3102698578ns5:ShareCapital2024-12-3102698578ns5:SharePremium2025-12-3102698578ns5:SharePremium2024-12-3102698578ns5:CapitalRedemptionReserve2025-12-3102698578ns5:CapitalRedemptionReserve2024-12-3102698578ns5:RetainedEarningsAccumulatedLosses2025-12-3102698578ns5:RetainedEarningsAccumulatedLosses2024-12-3102698578ns5:LandBuildings2024-12-3102698578ns5:FurnitureFittings2024-12-3102698578ns5:ComputerEquipment2024-12-3102698578ns5:LandBuildings2025-01-012025-12-3102698578ns5:FurnitureFittings2025-01-012025-12-3102698578ns5:ComputerEquipment2025-01-012025-12-3102698578ns5:LandBuildings2025-12-3102698578ns5:FurnitureFittings2025-12-3102698578ns5:ComputerEquipment2025-12-3102698578ns5:LandBuildings2024-12-3102698578ns5:FurnitureFittings2024-12-3102698578ns5:ComputerEquipment2024-12-3102698578ns5:WithinOneYearns5:CurrentFinancialInstruments2025-12-3102698578ns5:WithinOneYearns5:CurrentFinancialInstruments2024-12-3102698578ns5:Non-currentFinancialInstruments2025-12-3102698578ns5:Non-currentFinancialInstruments2024-12-3102698578ns5:RetainedEarningsAccumulatedLosses2024-12-3102698578ns5:SharePremium2024-12-3102698578ns5:CapitalRedemptionReserve2024-12-3102698578ns5:RetainedEarningsAccumulatedLosses2025-01-012025-12-31
REGISTERED NUMBER: 02698578 (England and Wales)















Unaudited Financial Statements for the Year Ended 31 December 2025

for

Micromode Medical Limited

Micromode Medical Limited (Registered number: 02698578)






Contents of the Financial Statements
for the Year Ended 31 December 2025




Page

Company Information 1

Statement of Financial Position 2

Notes to the Financial Statements 4

Chartered Accountants' Report 7

Micromode Medical Limited

Company Information
for the Year Ended 31 December 2025







DIRECTORS: Mr S Thakker
Mr D W Nathanson





SECRETARY: Mr S Thakker





REGISTERED OFFICE: Unit 514 Centennial Avenue
Centennial Park
Elstree
Hertfordshire
WD6 3FG





REGISTERED NUMBER: 02698578 (England and Wales)





ACCOUNTANTS: Andrew Murray & Co
Business Advisors and Statutory Auditors
144-146 Kings Cross Road
King's Cross
WC1X 9DU

Micromode Medical Limited (Registered number: 02698578)

Statement of Financial Position
31 December 2025

31.12.25 31.12.24
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 4 19,892 6,100

CURRENT ASSETS
Stocks 314,559 267,013
Debtors 5 28,500 123,953
Prepayments and accrued income 111,637 91,797
Cash at bank and in hand 3,062,808 2,809,220
3,517,504 3,291,983
CREDITORS
Amounts falling due within one year 6 824,208 1,470,294
NET CURRENT ASSETS 2,693,296 1,821,689
TOTAL ASSETS LESS CURRENT
LIABILITIES

2,713,188

1,827,789

PROVISIONS FOR LIABILITIES 7 100,000 100,000
NET ASSETS 2,613,188 1,727,789

CAPITAL AND RESERVES
Called up share capital 136 136
Share premium 8 22,860 22,860
Capital redemption reserve 8 200 200
Retained earnings 8 2,589,992 1,704,593
2,613,188 1,727,789

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 December 2025.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 December 2025 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

Micromode Medical Limited (Registered number: 02698578)

Statement of Financial Position - continued
31 December 2025


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 24 September 2026 and were signed on its behalf by:





Mr S Thakker - Director


Micromode Medical Limited (Registered number: 02698578)

Notes to the Financial Statements
for the Year Ended 31 December 2025

1. STATUTORY INFORMATION

Micromode Medical Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.

Stocks
Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the statement of financial position date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the statement of financial position date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Hire purchase and leasing commitments
Rentals paid under operating leases are charged to profit or loss on a straight line basis over the period of the lease.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

Micromode Medical Limited (Registered number: 02698578)

Notes to the Financial Statements - continued
for the Year Ended 31 December 2025

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 24 (2024 - 23 ) .

4. TANGIBLE FIXED ASSETS
Fixtures
Freehold and Computer
property fittings equipment Totals
£    £    £    £   
COST
At 1 January 2025 17,106 73,596 17,553 108,255
Additions - 700 15,869 16,569
Disposals - (73,199 ) (15,181 ) (88,380 )
At 31 December 2025 17,106 1,097 18,241 36,444
DEPRECIATION
At 1 January 2025 12,830 73,405 15,920 102,155
Charge for year 856 239 1,682 2,777
Eliminated on disposal - (73,199 ) (15,181 ) (88,380 )
At 31 December 2025 13,686 445 2,421 16,552
NET BOOK VALUE
At 31 December 2025 3,420 652 15,820 19,892
At 31 December 2024 4,276 191 1,633 6,100

5. DEBTORS
31.12.25 31.12.24
£    £   
Amounts falling due within one year:
Trade debtors - 13,551
Advances to Suppliers - 86,652
- 100,203

Amounts falling due after more than one year:
Other debtors 28,500 23,750

Aggregate amounts 28,500 123,953

Micromode Medical Limited (Registered number: 02698578)

Notes to the Financial Statements - continued
for the Year Ended 31 December 2025

6. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.12.25 31.12.24
£    £   
Trade creditors 291,234 485,189
Tax 274,115 -
Social security and other taxes 41,603 35,393
Pension Control 3,957 7,035
VAT 148,252 89,448
Other creditors 2,858 797,336
Directors' current accounts - 151
Accrued expenses 62,189 55,742
824,208 1,470,294

7. PROVISIONS FOR LIABILITIES
31.12.25 31.12.24
£    £   
Other provisions 100,000 100,000

8. RESERVES
Capital
Retained Share redemption
earnings premium reserve Totals
£    £    £    £   

At 1 January 2025 1,704,593 22,860 200 1,727,653
Profit for the year 885,399 885,399
At 31 December 2025 2,589,992 22,860 200 2,613,052

9. CONTINGENT LIABILITIES

The company has guaranteed a bank loan on behalf of Shield Property Holdings LLP, an entity in which the directors are members. The loan outstanding as at the balance sheet date was £526,195. (2024: £587,613).

10. RELATED PARTY TRANSACTIONS

The company paid rent of £114,000 to Shield Property Holdings LLP (2024: £114,000) an entity in which the
directors are members. The rent was paid under normal commercial terms. The amount owed to Shield Property Holdings LLP at the balance sheet date was £31,925 (2024: Nil)

Chartered Accountants' Report to the Board of Directors
on the Unaudited Financial Statements of
Micromode Medical Limited

The following reproduces the text of the report prepared for the directors in respect of the company's annual unaudited financial statements. In accordance with the Companies Act 2006, the company is only required to file a Statement of Financial Position. Readers are cautioned that the Income Statement and certain other primary statements and the Directors' Report are not required to be filed with the Registrar of Companies.

In order to assist you to fulfil your duties under the Companies Act 2006, we have prepared for your approval the financial statements of Micromode Medical Limited for the year ended 31 December 2025 which comprise the Income Statement, Statement of Financial Position and the related notes from the company's accounting records and from information and explanations you have given us.

As a practising member firm of the Institute of Chartered Accountants in England and Wales (ICAEW), we are subject to its ethical and other professional requirements which are detailed within the ICAEW's regulations and guidance at http://www.icaew.com/en/membership/regulations-standards-and-guidance.

This report is made solely to the Board of Directors of Micromode Medical Limited, as a body, in accordance with our terms of engagement. Our work has been undertaken solely to prepare for your approval the financial statements of Micromode Medical Limited and state those matters that we have agreed to state to the Board of Directors of Micromode Medical Limited, as a body, in this report in accordance with ICAEW Technical Release 07/16AAF. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than Micromode Medical Limited and its Board of Directors, as a body, for our work or for this report.

It is your duty to ensure that Micromode Medical Limited has kept adequate accounting records and to prepare statutory financial statements that give a true and fair view of the assets, liabilities, financial position and profit of Micromode Medical Limited. You consider that Micromode Medical Limited is exempt from the statutory audit requirement for the year.

We have not been instructed to carry out an audit or a review of the financial statements of Micromode Medical Limited. For this reason, we have not verified the accuracy or completeness of the accounting records or information and explanations you have given to us and we do not, therefore, express any opinion on the statutory financial statements.






Andrew Murray & Co
Business Advisors and Statutory Auditors
144-146 Kings Cross Road
King's Cross
WC1X 9DU


Date: .............................................